BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Staging
2 results:

  • 1. Which N Descriptor Is More Predictive of Prognosis in Resected Non-small Cell lung cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
    Xu L; Su H; She Y; Dai C; Zhao M; Gao J; Xie H; Ren Y; Xie D; Chen C
    Chest; 2021 Jun; 159(6):2458-2469. PubMed ID: 33352193
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Nodal Restaging Based on CEACAM5, FGFR2b and ptpn11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell lung cancer.
    Macia I; Aiza G; Ramos R; Escobar I; Rivas F; UreƱa A; Aso S; Rosado G; Rodriguez-Taboada P; Deniz C; Nadal E; Capella G
    J Invest Surg; 2022 Feb; 35(2):315-324. PubMed ID: 33342327
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.